Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarriers Controls Chemotherapy-Induced Alopecia Areata

    Yeneng Guan, Aqin Yan, Qiang Wang, Rui Ruan, Chaobo Yang, Kai Ma, Hongmei Sun, Mingxing Liu, Hongda Zhu
    Image of study
    TLDR A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.
    The study presents a novel approach to treating chemotherapy-induced alopecia areata (AA) using lipid-coated calcium carbonate nanoparticles (PL/ACC NPs) to deliver Tofacitinib Citrate (TFC) directly to hair follicles. The PL/ACC-TFC NPs showed excellent pH sensitivity and transdermal penetration in vitro. In a Cyclophosphamide (CYP)-induced AA mouse model, these nanoparticles significantly promoted hair growth and alleviated AA more effectively than the TFC solution group. The study also found that TFC reduced the secretion of ectopic MHC molecules, which are overexpressed in AA. However, TFC's protective effect on hair follicles might be greater than its repair effect. The study concludes that PL/ACC-TFC NPs have potential for use in the prevention and mitigation of CYP-induced AA.
    Discuss this study in the Community →

    Research cited in this study

    20 / 20 results

    Related Community Posts Join

    6 / 6 results

    Related Research

    5 / 5 results